Rapid development of key mutation detection reagents continues to facilitate critical investigation and monitoring activities SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd., a developer of innovative ...
SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has partnered with Roche (SIX: RO, ROG; OTCQX: RHHBY), a global pioneer in pharmaceuticals and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback